The US Food and Drug Administration (FDA) has approved the emergency use authorization of COVID-19 vaccines from Moderna and Pfizer in young infants.
FDA expanded the vaccine authorizations to encompass infants as young as six months on Friday.
“Many parents, caregivers, and clinicians have been waiting for a vaccine for younger children and this action will help protect those down to 6 months of age. As we have seen with older age groups, we expect that the vaccines for younger children will provide protection from the most severe outcomes of COVID-19, such as hospitalization and death,” said FDA Commissioner Robert Califf.
Califf assured the safety and effectiveness of the COVID-19 vaccines as FDA “was thorough in its evaluation of the data”.
Shots can’t be given until the vaccine advisors at the US Centers for Disease Control and Prevention (CDC) decide on whether to recommend them (a vote is set for Saturday) while CDC Director Dr. Rochelle Walensky signs off on the suggestion.
Previously, the Pfizer/BioNTech vaccine was licensed for people aged 5 to 16 years old, while Moderna’s vaccine was only approved for adults.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.